1. Anderson ED, Thomas L, Hayflick JS, Thomas G (1993) Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed α1-antitrypsin variant. J Biol Chem 268(33):24887–24891
2. Aulak KS, Eldering E, Hack CE, Lubbers YP, Harrison RA, Mast A, Cicardi M, Davis AE (1993) A hinge region mutation in C1-inhibitor (Ala436 → Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J Biol Chem 268(24):18088–18094
3. Baglin TP, Carrell RW, Church FC, Esmon CT, Huntington JA (2002) Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc Natl Acad Sci USA 99(17):11079–11084. doi: 10.1073/pnas.162232399
4. Basak A, Lotfipour F (2005) Modulating furin activity with designed mini-PDX peptides: synthesis and in vitro kinetic evaluation. FEBS Lett 579(21):4813–4821. doi: 10.1016/j.febslet.2005.07.062
5. Björk I, Ylinenjärvi K, Olson ST, Bock PE (1992) Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor. J Biol Chem 267(3):1976–1982